NASDAQ · BIOTW

Instinct Bio Technical Company Holdings Inc. Warrants (BIOTW)

$0.01510.00%
Close Sep 29, 2026 · split-adjusted
Sep 29, 2026$0.02▼ 10.65% in range
Sep 11, 2026Low $0.02 · High $0.02Sep 29, 2026
What changed · written from our data
As of Sep 29, 2026

Instinct Bio Technical Company Holdings Inc. Warrants closed at $0.02 on Sep 29, unchanged, within 0.0% of its lowest close since Mar 18. Volume of 11.7K shares was 0.95× its 20-day average (close to normal).

Short interest was 50.1K shares at the Sep 15 settlement, down 15.0% from the prior report (3.2 days to cover).

Market cap—
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yieldNone
Range since Mar 180.02 – 0.02−28.4% from high
Volume11.7K0.95× 20-day avg
Volatility · 60d—Annualised
Short % of float—3.2 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −0.7%1M —3M —6M —YTD —1Y —3Y —5Y −97.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short50.1K−15.0% vs prior
Days to cover3.2Settled Sep 15
% of float—
Short vol. 10d25.8%of daily volume

Quick answers

What does Instinct Bio Technical Company Holdings Inc. Warrants do?
Instinct Bio Technical Company Holdings Inc is a Cayman Islands-based vertically integrated group engaged in the research and development, manufacturing, branding, and distribution of stem cells, regenerative medicine, wellness, and beauty as its core areas. Its product portfolio includes stem cell-derived serums and skincare formulations for aesthetic and dermatological applications.

About Instinct Bio Technical Company Holdings Inc. Warrants

Instinct Bio Technical Company Holdings Inc is a Cayman Islands-based vertically integrated group engaged in the research and development, manufacturing, branding, and distribution of stem cells, regenerative medicine, wellness, and beauty as its core areas. Its product portfolio includes stem cell-derived serums and skincare formulations for aesthetic and dermatological applications. The company also develops regenerative products for skin healing, hydration, and elasticity.

Listed Jul 24, 2026instinct-biot.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology